Furthermore, by using a cell collection with tetracycline-inducible shBMPR2, we found that the knockdown of BMPR2 significantly decreased the senescent cells even in the presence of BMP7 (Tet+/+, BMP7), whereas the withdrawal of tetracycline (i

Furthermore, by using a cell collection with tetracycline-inducible shBMPR2, we found that the knockdown of BMPR2 significantly decreased the senescent cells even in the presence of BMP7 (Tet+/+, BMP7), whereas the withdrawal of tetracycline (i.e., the recovery of BMPR2 manifestation) ameliorated the effect of BMP7 within the induction of senescence (Tet+/, BMP7;Fig. BMPR2 manifestation inversely correlated with recurrence and bone metastasis in prostate cancer patients. Importantly, this BMP7-induced senescence in CSCs was reversible upon withdrawal of BMP7. Furthermore, treatment of mice with BMP7 significantly suppressed the growth of CSCs in bone, whereas the withdrawal of BMP7 restarted growth of these cells. These results suggest that the BMP7BMPR2p38NDRG1 axis plays a critical part in dormancy and recurrence of prostate CSCs in bone and suggest a potential restorative energy of BMP7 for recurrent metastatic disease. Despite significant improvement in recent therapeutic systems, >90% of the cancer deaths are still attributed to metastatic disease (Peinado et al., 2008). In the case of prostate and breast cancers, 2050% individuals who have localized cancer and have been successfully treated with surgical treatment eventually experience recurrent disease after many years (Karrison et al., 1999;Weckermann et al., 2001;Pfitzenmaier et al., 2006). How metastatic tumor cells become dormant in the distant organs is virtually unknown. However, because NMDI14 recurrent disease is almost always fatal, it is of paramount importance to elucidate the fundamental molecular mechanism of dormancy and recurrence to identify novel therapeutic focuses on. The dormant state of metastatic cell is thought to be controlled by both genetic changes in tumor cell and microenvironment of the metastasized organs (Aguirre-Ghiso, 2007). According to the recent tumor stem cell theory, metastatic cells must have stem-like characteristics such as capabilities of self-renewal and differentiation in addition to their invasive ability (Pantel and Alix-Panabires, 2007;Polyak and Weinberg, 2009). Consequently, only a portion of main tumor cells is able to NMDI14 establish colonization in the distant organ and NMDI14 also become dormant. However, because dormant lesions in most cases consist of a solitary or small number of tumor cells, they are clinically undetectable, which significantly hampers the progress of research with this field. This dormant state is thought to be managed by virtue of the balance of local microenvironment such as stromatumor cell conversation and secreted growth factors and pro- and antiangiogenic factors, as well as local immune system (Derynck et al., 2001;Bhowmick et al., 2004;Aguirre-Ghiso, 2007). The most critical question is to identify such important players that modulate the tumor cell dormancy and to dissect the responsive signaling pathways. Recently, others exhibited, through a series of elegant experiments, the signaling cascade that is controlled by the balance of two prominent pathways, p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK), is the important determining element for tumor cell dormancy (Aguirre-Ghiso et al., 2001,2003,2004;Aguirre-Ghiso, 2007). p38 signaling is also known to be involved in the regulation of cell cycle arrest and plays a crucial part in the induction of senescence in response to a variety of stress, including oncogenic stress (Bulavin and Fornace, 2004;Bulavin et al., 2004;Dasari et al., 2006;Tront et NMDI14 al., 2006;Han and Sun, 2007;Sun et al., 2007;Wagner and Nebreda, 2009). A high percentage of ERK/p38 NMDI14 manifestation was indeed observed in metastatic lesions in an animal model of ovarian cancer, which supports the notion that the balance of ERK and p38 determines the fate of disseminated tumor cells whether to proliferate or stay in dormant state in the distant organ (Aguirre-Ghiso et al., 2004). However, extracellular factors in the microenvironment, either cellcell conversation or secretory factors, that regulate p38 signaling and modulate the concomitant tumor cell dormancy and recurrence are yet to be identified. In this study, we found that one of the TGF- family members, BMP7 (bone morphogenetic protein 7), which is secreted from bone stromal cells, induces senescence through activation of p38 MAPK, cell cycle inhibitor, p21, and the tumor metastasis suppressor gene,NDRG1(N-myc downstream-regulated gene 1) in prostate cancer stem-like cells (CSCs). Importantly, this BMP7-induced senescence was found to be reversible, indicating that BMP7 plays a critical part in tumor dormancy and recurrence. Our results also suggest that focusing on BMP7 signaling may become effective therapeutics to prevent recurrence of metastatic prostate cancer. == RESULTS == == A secretory element from bone stromal cells suppresses the growth of prostate cancer cells == Rabbit Polyclonal to PIK3C2G Bone stromal cells are considered to play a critical part in generating a niche for metastasized tumor cells by secreting numerous growth-inhibitory as well as growth-promoting factors in the microenvironment, which may contribute to tumor dormancy and recurrence (McAllister et al., 2008;Zhang et al., 2009). In an attempt to identify such factors, we 1st cultured Personal computer3 mm, a metastatic prostate cancer cell line, in the presence of the conditioned medium (CM) of human being BM stromal cells (HS5). We found that the CM of HS5 significantly promoted the manifestation of.